On model prespecification in confirmatory randomized studies

Statistics in Medicine

Volumn 18, Issue 7, 1999, Pages 771-785

  Edwards, David ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL;

BIAS (EPIDEMIOLOGY); COMPUTER SIMULATION; HUMANS; LINEAR MODELS; MODELS, STATISTICAL; MONTE CARLO METHOD; RANDOMIZED CONTROLLED TRIALS; REGRESSION ANALYSIS; TREATMENT OUTCOME;

EID: 0033561615     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19990415)18:7<771::AID-SIM80>3.0.CO;2-E     Document Type: Article

References (25)

1. 'Statistical Considerations in the Design of Clinical Trials'. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1998.
2. Food and Drug Administration. 'Guideline for the format and content of the clinical and statistical sections of an application', FDA, US Department of Health and Human Services, Rockville, MA, U.S.A. 1988.
3. CPMP Working Party on Efficacy of Medicinal Products. 'Biostatistical methodology in clinical trials in applications for marketing authorizations for medicinal products', Statistics in Medicine, 14, 1659-1682 (1995).
4. Rosenbaum, P. R. Observational Studies, Springer-Verlag, New York, 1995.
5. Fisher, R. A. The Design of Experiments, Hafner, New York.
6. Kempthorne, O. 'Some aspects of experimental inference', Journal of the American Statistical Association, 61, 11-34 (1966).
7. Tukey, J. W. 'Tightening the clinical trial', Controlled Clinical Trials, 14, 266-285 (1993).
8. Gail, M. H., Mark, S. D., Carroll, R. J., Green, S. B. and Pee, D. 'On design considerations and randomisation-based inference for community intervention trials', Statistics in Medicine, 15, 1069-1092 (1996).
9. Romano, J. P. 'On the behavior of randomisation tests without a group invariance assumption', Journal of the American Statistical Association, 85, 411, 696-692 (1990).
10. Hoeffding, W. 'The large-sample power of tests based on permutations of observations', Annals of Mathematical Statistics, 23, 169-192 (1952).
11. Neuhaus, J. M. 'Misspecification', Encyclopedia of Biostatistics, Volume 4, Wiley, Chichester, 1998, pp. 2654-2657.
12. Keiding, N., Andersen, P. K. and Klein, J. P. 'The role of frailty models and accelerated failure time models in describing heterogeneity due to omitted covariates'. Statistics in Medicine, 16, 215-224 (1997).
13. Gail, M. H., Tan, W. Y. and Piantadosi, S. 'Tests for no treatment effect in randomised clinical trials', Biometrika, 75, 1, 57-64 (1988).
14. Akaike, H. 'Fitting autoregressive models for prediction', Annals of the Institute of Statistical Mathematics, 21, 243-247 (1969).
15. Schwarz, G. 'Estimating the dimension of a model', Annals of Statistics, 6, 461-464 (1978).
16. Chatfield, C. 'Model uncertainty, data mining and statistical inference (with discussion)', Journal of the Royal Statistical Society, Series A, 158, 3, 419-466 (1995).
17. Piantadosi, S. Clinical Trials: A Methodological Perspective, Wiley, New York, 1997.
18. Good, P. Permutation Tests, Springer-Verlag, New York, 1994.
19. Tritchler, D. 'On inverting permutation tests', Journal of the American Statistical Association, 79, 385, 200-207 (1984).
20. Garthwaite, P. H. 'Confidence intervals from randomisation tests', Biometrics, 52, 1387-1393 (1996).
21. Edwards, D. Introduction to Graphical Modelling, Springer-Verlag, New York, 1995.
22. Senn, S. Statistical Issues in Drug Development, Wiley, Chichester, 1997.
23. Tukey, J. W. 'Use of many covariates in clinical trials', International Statistical Review, 59, 2, 123-137 (1991).
24. Lewis, J. A. 'Statistical issues in the regulation of medicines', Statistics in Medicine, 14, 127-136 (1995).
25. Brillinger, D. R., Jones, L. V. and Tukey, J. W. 'The role of statistics in weather resource management', Report of the Statistical Task Force to the Weather Modification Advisory Board, 1978.